TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2284033
log Bayes Factor = 0.816696
Chromosome 22   position 37,534,034  (GRCh37) Explore rs2284033 on Ensembl!
Variant rs2284033 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
E10 Insulin-dependent diabetes mellitus
0.000 0.148 0.852
E10.3 With ophthalmic complications
0.000 0.149 0.851
E10.9 Without complications
0.000 0.166 0.834
E10.1 With ketoacidosis
0.000 0.208 0.792
E10.8 With unspecified complications
0.000 0.265 0.735
E10.2 With renal complications
0.000 0.269 0.731
E10.6 With other specified complications
0.000 0.279 0.721
E10.0 With coma
0.000 0.291 0.709
E10.7 With multiple complications
0.000 0.388 0.612
E10.4 With neurological complications
0.000 0.463 0.537
E10-E14 Diabetes mellitus
0.000 0.556 0.444
E11 Non-insulin-dependent diabetes mellitus
0.000 0.583 0.417
E11.4 With neurological complications
0.000 0.603 0.397
E11.8 With unspecified complications
0.000 0.604 0.396
E11.5 With peripheral circulatory complications
0.000 0.619 0.381
E10.5 With peripheral circulatory complications
0.000 0.630 0.370
E12 Malnutrition-related diabetes mellitus
0.000 0.681 0.318
E11.0 With coma
0.000 0.691 0.309
E11.7 With multiple complications
0.000 0.704 0.296
E11.2 With renal complications
0.000 0.717 0.283
E13 Other specified diabetes mellitus
0.000 0.736 0.264
E11.6 With other specified complications
0.000 0.738 0.262
E12.9 Without complications
0.000 0.771 0.228
E12.8 With unspecified complications
0.000 0.771 0.228
E12.7 With multiple complications
0.000 0.771 0.228
E12.6 With other specified complications
0.000 0.771 0.228
E12.5 With peripheral circulatory complications
0.000 0.771 0.228
E12.4 With neurological complications
0.000 0.771 0.228
E12.3 With ophthalmic complications
0.000 0.771 0.228
E12.2 With renal complications
0.000 0.771 0.228
E12.1 With ketoacidosis
0.000 0.771 0.228
E12.0 With coma
0.000 0.771 0.228
E11.1 With ketoacidosis
0.000 0.782 0.217
E13.8 With unspecified complications
0.000 0.810 0.190
E13.7 With multiple complications
0.000 0.810 0.190
E13.6 With other specified complications
0.000 0.810 0.190
E13.5 With peripheral circulatory complications
0.000 0.810 0.190
E13.4 With neurological complications
0.000 0.810 0.190
E13.2 With renal complications
0.000 0.810 0.190
E13.1 With ketoacidosis
0.000 0.810 0.190
E13.0 With coma
0.000 0.810 0.190
E13.3 With ophthalmic complications
0.000 0.811 0.189
E11.3 With ophthalmic complications
0.000 0.833 0.167
E14 Unspecified diabetes mellitus
0.000 0.857 0.143
E13.9 Without complications
0.000 0.863 0.136
E14.4 With neurological complications
0.000 0.891 0.109
E14.1 With ketoacidosis
0.000 0.892 0.108
E14.8 With unspecified complications
0.000 0.892 0.108
E14.2 Withrenal complications
0.000 0.896 0.104
E14.7 With multiple complications
0.000 0.897 0.103
E14.0 With coma
0.000 0.897 0.103
E14.6 With other specified complications
0.000 0.911 0.089
E14.9 Without complications
0.000 0.921 0.079
J32.9 Chronic sinusitis, unspecified
0.000 0.922 0.078
E05.9 Thyrotoxicosis, unspecified
0.000 0.924 0.076
E14.5 With peripheral circulatory complications
0.000 0.928 0.072
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.931 0.069
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.934 0.066
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.945 0.055
E00-E07 Disorders of thyroid gland
0.000 0.947 0.053
E14.3 With ophthalmic complications
0.000 0.947 0.053
E05.5 Thyroid crisis or storm
0.000 0.950 0.049
E05.4 Thyrotoxicosis factitia
0.000 0.950 0.049
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.950 0.049
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.950 0.049
E05.8 Other thyrotoxicosis
0.000 0.954 0.045
E65-E68 Obesity and other hyperalimentation
0.000 0.955 0.045
E03 Other hypothyroidism
0.000 0.957 0.043
E03.9 Hypothyroidism, unspecified
0.000 0.959 0.041
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.959 0.041
J45.9 Asthma, unspecified
0.000 0.960 0.040
E66 Obesity
0.000 0.960 0.040
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.961 0.039
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.962 0.038
E00 Congenital iodine-deficiency syndrome
0.000 0.962 0.038
E66.8 Other obesity
0.000 0.962 0.038
J32 Chronic sinusitis
0.000 0.966 0.034
E67 Other hyperalimentation
0.000 0.968 0.032
E68 Sequelae of hyperalimentation
0.000 0.968 0.032
E03.5 Myxoedema coma
0.000 0.969 0.031
E03.4 Atrophy of thyroid (acquired)
0.000 0.969 0.031
E03.3 Postinfectious hypothyroidism
0.000 0.969 0.031
E03.1 Congenital hypothyroidism without goitre
0.000 0.969 0.031
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.969 0.031
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.971 0.029
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.971 0.029
E40-E46 Malnutrition
0.000 0.971 0.029
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.971 0.029
E66.1 Drug-induced obesity
0.000 0.971 0.029
J32.8 Other chronic sinusitis
0.000 0.972 0.028
E15 Nondiabetic hypoglycaemic coma
0.000 0.972 0.028
J32.0 Chronic maxillary sinusitis
0.000 0.972 0.028
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.972 0.028
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.972 0.028
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.972 0.028
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.972 0.028
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.972 0.028
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.972 0.028
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.972 0.028
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.972 0.028
E66.9 Obesity, unspecified
0.000 0.973 0.027
E16 Other disorders of pancreatic internal secretion
0.000 0.973 0.027
E66.0 Obesity due to excess calories
0.000 0.974 0.026
E65 Localised adiposity
0.000 0.974 0.026
J32.4 Chronic pansinusitis
0.000 0.975 0.025
J32.1 Chronic frontal sinusitis
0.000 0.975 0.025
E07 Other disorders of thyroid
0.000 0.975 0.024
J32.3 Chronic sphenoidal sinusitis
0.000 0.976 0.024
E06 Thyroiditis
0.000 0.976 0.023
E67.8 Other specified hyperalimentation
0.000 0.977 0.023
E67.3 Hypervitaminosis D
0.000 0.977 0.023
E67.2 Megavitamin-B6 syndrome
0.000 0.977 0.023
E67.1 Hypercarotenaemia
0.000 0.977 0.023
E67.0 Hypervitaminosis A
0.000 0.977 0.023
E03.8 Other specified hypothyroidism
0.000 0.977 0.023
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.977 0.023
E27 Other disorders of adrenal gland
0.000 0.979 0.021
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.979 0.021
E45 Retarded development following protein-energy malnutrition
0.000 0.979 0.021
E43 Unspecified severe protein-energy malnutrition
0.000 0.979 0.021
E42 Marasmic kwashiorkor
0.000 0.979 0.021
E41 Nutritional marasmus
0.000 0.979 0.021
E40 Kwashiorkor
0.000 0.979 0.021
E16.2 Hypoglycaemia, unspecified
0.000 0.979 0.021
E20-E35 Disorders of other endocrine glands
0.000 0.979 0.021
C85.1 B-cell lymphoma, unspecified
0.000 0.980 0.020
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.980 0.020
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.980 0.020
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.980 0.020
E16.4 Abnormal secretion of gastrin
0.000 0.980 0.020
E16.3 Increased secretion of glucagon
0.000 0.980 0.020
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.980 0.020
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.981 0.019
E27.9 Disorder of adrenal gland, unspecified
0.000 0.982 0.018
I08.3 Combined disorders of mitral, aortic and tricuspid valves
0.000 0.982 0.018
E07.1 Dyshormogenetic goitre
0.000 0.982 0.018
E07.0 Hypersecretion of calcitonin
0.000 0.982 0.018
E16.1 Other hypoglycaemia
0.000 0.983 0.017
E06.4 Drug-induced thyroiditis
0.000 0.983 0.017
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.983 0.017
E06.0 Acute thyroiditis
0.000 0.983 0.017
E27.8 Other specified disorders of adrenal gland
0.000 0.983 0.017
E27.1 Primary adrenocortical insufficiency
0.000 0.983 0.017
E25 Adrenogenital disorders
0.000 0.984 0.016
E20 Hypoparathyroidism
0.000 0.984 0.016
E06.5 Other chronic thyroiditis
0.000 0.984 0.016
E07.8 Other specified disorders of thyroid
0.000 0.984 0.016
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.984 0.016
E06.1 Subacute thyroiditis
0.000 0.984 0.016
E27.5 Adrenomedullary hyperfunction
0.000 0.985 0.015
E27.0 Other adrenocortical overactivity
0.000 0.985 0.015
E44.1 Mild protein-energy malnutrition
0.000 0.985 0.015
E44.0 Moderate protein-energy malnutrition
0.000 0.985 0.015
E50-E64 Other nutritional deficiencies
0.000 0.985 0.015
E06.3 Autoimmune thyroiditis
0.000 0.985 0.015
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.985 0.015
E32 Diseases of thymus
0.000 0.985 0.015
E30 Disorders of puberty, not elsewhere classified
0.000 0.985 0.015
E23 Hypofunction and other disorders of pituitary gland
0.000 0.985 0.015
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.985 0.015
E20.9 Hypoparathyroidism, unspecified
0.000 0.985 0.014
E27.2 Addisonian crisis
0.000 0.986 0.014
E31 Polyglandular dysfunction
0.000 0.986 0.014
H02.5 Other disorders affecting eyelid function
0.000 0.986 0.014
C85.0 Lymphosarcoma
0.000 0.986 0.014
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.986 0.014
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.986 0.013
J33.9 Nasal polyp, unspecified
0.000 0.986 0.014
E26 Hyperaldosteronism
0.000 0.987 0.013
J44.9 Chronic obstructive pulmonary disease, unspecified
0.000 0.987 0.013
E23.6 Other disorders of pituitary gland
0.000 0.987 0.013
M81.98 Osteoporosis, unspecified (Other)
0.000 0.988 0.012
E22 Hyperfunction of pituitary gland
0.000 0.988 0.012
E25.9 Adrenogenital disorder, unspecified
0.000 0.988 0.012
E25.8 Other adrenogenital disorders
0.000 0.988 0.012
E20.1 Pseudohypoparathyroidism
0.000 0.988 0.012
E20.0 Idiopathic hypoparathyroidism
0.000 0.988 0.012
E34 Other endocrine disorders
0.000 0.988 0.012
J45 Asthma
0.000 0.988 0.012
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.989 0.011
E50 Vitamin A deficiency
0.000 0.989 0.011
E60 Dietary zinc deficiency
0.000 0.989 0.011
E59 Dietary selenium deficiency
0.000 0.989 0.011
E54 Ascorbic acid deficiency
0.000 0.989 0.011
E52 Niacin deficiency [pellagra]
0.000 0.989 0.011
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.000 0.989 0.011
E29 Testicular dysfunction
0.000 0.989 0.011
E30.9 Disorder of puberty, unspecified
0.000 0.989 0.011
E30.8 Other disorders of puberty
0.000 0.989 0.011
E30.1 Precocious puberty
0.000 0.989 0.011
E30.0 Delayed puberty
0.000 0.989 0.011
E32.9 Disease of thymus, unspecified
0.000 0.989 0.011
E32.8 Other diseases of thymus
0.000 0.989 0.011
E32.1 Abscess of thymus
0.000 0.989 0.011
E32.0 Persistent hyperplasia of thymus
0.000 0.989 0.011
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.989 0.011
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.989 0.011
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.989 0.011
E06.9 Thyroiditis, unspecified
0.000 0.989 0.011
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.989 0.011
E23.1 Drug-induced hypopituitarism
0.000 0.989 0.011
E58 Dietary calcium deficiency
0.000 0.989 0.011
E11.9 Without complications
0.000 0.989 0.011
E56 Other vitamin deficiencies
0.000 0.989 0.011
R02 Gangrene, not elsewhere classified
0.000 0.989 0.011
J44 Other chronic obstructive pulmonary disease
0.000 0.989 0.011
E51 Thiamine deficiency
0.000 0.989 0.010
E26.9 Hyperaldosteronism, unspecified
0.000 0.989 0.010
E23.7 Disorder of pituitary gland, unspecified
0.000 0.989 0.010
E63 Other nutritional deficiencies
0.000 0.989 0.010
E31.9 Polyglandular dysfunction, unspecified
0.000 0.989 0.010
E31.8 Other polyglandular dysfunction
0.000 0.989 0.010
E31.1 Polyglandular hyperfunction
0.000 0.989 0.010
E53 Deficiency of other B group vitamins
0.000 0.990 0.010
J32.2 Chronic ethmoidal sinusitis
0.000 0.990 0.010
E20.8 Other hypoparathyroidism
0.000 0.990 0.010
E46 Unspecified protein-energy malnutrition
0.000 0.990 0.010
E26.8 Other hyperaldosteronism
0.000 0.990 0.010
E26.1 Secondary hyperaldosteronism
0.000 0.990 0.010
E31.0 Autoimmune polyglandular failure
0.000 0.990 0.010
E23.2 Diabetes insipidus
0.000 0.990 0.009
E22.1 Hyperprolactinaemia
0.000 0.991 0.009
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.009 0.991 0.000
J45.1 Nonallergic asthma
0.000 0.991 0.009
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.991 0.009
E22.8 Other hyperfunction of pituitary gland
0.000 0.991 0.009
E23.0 Hypopituitarism
0.000 0.991 0.009
E28 Ovarian dysfunction
0.000 0.991 0.009
E34.8 Other specified endocrine disorders
0.000 0.991 0.009
E34.5 Androgen resistance syndrome
0.000 0.991 0.009
E34.4 Constitutional tall stature
0.000 0.991 0.009
E34.3 Short stature, not elsewhere classified
0.000 0.991 0.009
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.991 0.009
E34.1 Other hypersecretion of intestinal hormones
0.000 0.991 0.009
E29.8 Other testicular dysfunction
0.000 0.992 0.008
E29.0 Testicular hyperfunction
0.000 0.992 0.008
E50.9 Vitamin A deficiency, unspecified
0.000 0.992 0.008
E50.8 Other manifestations of vitamin A deficiency
0.000 0.992 0.008
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.992 0.008
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.992 0.008
E50.5 Vitamin A deficiency with night blindness
0.000 0.992 0.008
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.992 0.008
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.992 0.008
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.992 0.008
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.992 0.008
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.992 0.008
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.992 0.008
E64.8 Sequelae of other nutritional deficiencies
0.000 0.992 0.008
E64.3 Sequelae of rickets
0.000 0.992 0.008
E64.2 Sequelae of vitamin C deficiency
0.000 0.992 0.008
E64.1 Sequelae of vitamin A deficiency
0.000 0.992 0.008
E64.0 Sequelae of protein-energy malnutrition
0.000 0.992 0.008
J33 Nasal polyp
0.000 0.992 0.008
B95.4 Other streptococcus as the cause of diseases classified to other chapters
0.000 0.992 0.008
E56.9 Vitamin deficiency, unspecified
0.000 0.992 0.008
E56.8 Deficiency of other vitamins
0.000 0.992 0.008
E56.0 Deficiency of vitamin E
0.000 0.992 0.008
E22.0 Acromegaly and pituitary gigantism
0.000 0.992 0.008
E51.9 Thiamine deficiency, unspecified
0.000 0.992 0.008
E51.8 Other manifestations of thiamine deficiency
0.000 0.992 0.008
E51.1 Beriberi
0.000 0.992 0.008
E29.9 Testicular dysfunction, unspecified
0.000 0.992 0.008
E63.8 Other specified nutritional deficiencies
0.000 0.992 0.008
E63.1 Imbalance of constituents of food intake
0.000 0.992 0.008
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.992 0.008
E53.1 Pyridoxine deficiency
0.000 0.992 0.008
E53.0 Riboflavin deficiency
0.000 0.992 0.008
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.992 0.008
E53.8 Deficiency of other specified B group vitamins
0.000 0.992 0.008
E56.1 Deficiency of vitamin K
0.000 0.992 0.007
E07.9 Disorder of thyroid, unspecified
0.000 0.992 0.008
E55 Vitamin D deficiency
0.000 0.992 0.007
E34.0 Carcinoid syndrome
0.000 0.992 0.007
E51.2 Wernicke's encephalopathy
0.000 0.993 0.007
J44.8 Other specified chronic obstructive pulmonary disease
0.000 0.993 0.007
E26.0 Primary hyperaldosteronism
0.000 0.993 0.007
E63.9 Nutritional deficiency, unspecified
0.000 0.993 0.007
U80.1 Methicillin resistant agent
0.000 0.993 0.007
E24 Cushing's syndrome
0.001 0.993 0.006
E34.9 Endocrine disorder, unspecified
0.000 0.993 0.007
E53.9 Vitamin B deficiency, unspecified
0.000 0.993 0.007
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.993 0.007
M81.9 Osteoporosis, unspecified
0.000 0.993 0.007
J33.0 Polyp of nasal cavity
0.000 0.993 0.007
M81.97 Osteoporosis, unspecified (Ankle and foot)
0.000 0.993 0.007
E28.9 Ovarian dysfunction, unspecified
0.000 0.993 0.006
E28.8 Other ovarian dysfunction
0.000 0.993 0.006
E28.1 Androgen excess
0.000 0.993 0.006
E28.0 Oestrogen excess
0.000 0.993 0.006
J40-J47 Chronic lower respiratory diseases
0.000 0.993 0.007
J45.8 Mixed asthma
0.000 0.993 0.006
U80 Agent resistant to penicillin and related antibiotics
0.000 0.993 0.007
E21.2 Other hyperparathyroidism
0.000 0.994 0.006
F45.8 Other somatoform disorders
0.006 0.994 0.000
E61 Deficiency of other nutrient elements
0.000 0.994 0.006
J33.8 Other polyp of sinus
0.000 0.994 0.006
U80.8 Agent resistant to other penicillin-related antibiotic
0.000 0.994 0.006
R25.1 Tremor, unspecified
0.000 0.994 0.006
E21.4 Other specified disorders of parathyroid gland
0.000 0.994 0.006
J33.1 Polypoid sinus degeneration
0.000 0.994 0.006
E55.0 Rickets, active
0.000 0.994 0.005
J47 Bronchiectasis
0.000 0.994 0.006
F45.9 Somatoform disorder, unspecified
0.005 0.995 0.000
U80.0 Penicillin resistant agent
0.000 0.995 0.005
E24.8 Other Cushing's syndrome
0.001 0.995 0.005
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.001 0.995 0.005
E24.3 Ectopic ACTH syndrome
0.001 0.995 0.005
E24.1 Nelson's syndrome
0.001 0.995 0.005
E29.1 Testicular hypofunction
0.000 0.995 0.005
F45 Somatoform disorders
0.005 0.995 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.995 0.005
M81.94 Osteoporosis, unspecified (Hand)
0.000 0.995 0.005
M81.92 Osteoporosis, unspecified (Upper arm)
0.000 0.995 0.005
M81.91 Osteoporosis, unspecified (Shoulder region)
0.000 0.995 0.005
U89.8 Agent resistant to other single specified antibiotic
0.000 0.995 0.005
E21.3 Hyperparathyroidism, unspecified
0.000 0.995 0.005
E28.3 Primary ovarian failure
0.000 0.995 0.005
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.995 0.005
M81.96 Osteoporosis, unspecified (Lower leg)
0.000 0.995 0.005
E61.9 Deficiency of nutrient element, unspecified
0.000 0.995 0.004
E61.8 Deficiency of other specified nutrient elements
0.000 0.995 0.004
E61.7 Deficiency of multiple nutrient elements
0.000 0.995 0.004
E61.6 Vanadium deficiency
0.000 0.995 0.004
E61.5 Molybdenum deficiency
0.000 0.995 0.004
E61.4 Chromium deficiency
0.000 0.995 0.004
E61.3 Manganese deficiency
0.000 0.995 0.004
E61.0 Copper deficiency
0.000 0.995 0.004
S06.00 Concussion (without open intracranial wound)
0.005 0.995 0.000
M81.93 Osteoporosis, unspecified (Forearm)
0.000 0.995 0.005
J31.0 Chronic rhinitis
0.000 0.995 0.005
F45.2 Hypochondriacal disorder
0.005 0.995 0.000
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)
0.000 0.995 0.004
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation
0.000 0.995 0.005
S92.30 Fracture of metatarsal bone (closed)
0.000 0.995 0.005
E24.2 Drug-induced Cushing's syndrome
0.001 0.995 0.004
J41 Simple and mucopurulent chronic bronchitis
0.000 0.995 0.004
U89 Agent resistant to other and unspecified antibiotics
0.000 0.996 0.004
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
0.000 0.996 0.004
E24.0 Pituitary-dependent Cushing's disease
0.001 0.996 0.004
R25 Abnormal involuntary movements
0.000 0.996 0.004
A63.0 Anogenital (venereal) warts
0.004 0.996 0.000
F45.0 Somatisation disorder
0.004 0.996 0.000
C81.1 Nodular sclerosis
0.000 0.996 0.004
M81.90 Osteoporosis, unspecified (Multiple sites)
0.000 0.996 0.004
F45.4 Persistent somatoform pain disorder
0.004 0.996 0.000
F45.1 Undifferentiated somatoform disorder
0.004 0.996 0.000
R25.8 Other and unspecified abnormal involuntary movements
0.000 0.996 0.004
M81.99 Osteoporosis, unspecified (Site unspecified)
0.000 0.996 0.004
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.000 0.996 0.004
U82-U85 Resistance to antimicrobial and antineoplastic drugs
0.000 0.996 0.004
J30-J39 Other diseases of upper respiratory tract
0.000 0.996 0.004
J46 Status asthmaticus
0.000 0.996 0.004
E28.2 Polycystic ovarian syndrome
0.000 0.996 0.004
C67.3 Anterior wall of bladder
0.004 0.996 0.000
R25.3 Fasciculation
0.000 0.996 0.004
J40 Bronchitis, not specified as acute or chronic
0.000 0.996 0.004
M81 Osteoporosis without pathological fracture
0.000 0.996 0.004
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.000 0.996 0.004
E61.2 Magnesium deficiency
0.001 0.996 0.003
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.000 0.996 0.003
J41.1 Mucopurulent chronic bronchitis
0.000 0.996 0.003
R25.2 Cramp and spasm
0.000 0.996 0.003
Chapter XXII Codes for special purposes
0.000 0.997 0.003
U50 Level of care administered to neonates
0.000 0.997 0.003
U07 Emergency use of U07
0.000 0.997 0.003
U06 Emergency use of U06
0.000 0.997 0.003
U04 Severe acute respiratory syndrome [SARS]
0.000 0.997 0.003
U52 First in a series of a regular day/night admissions
0.000 0.997 0.003
M43.02 Spondylolysis (Cervical region)
0.003 0.997 0.000
R25.0 Abnormal head movements
0.000 0.997 0.003
U89.9 Agent resistant to unspecified antibiotic
0.000 0.997 0.003
U81 Agent resistant to vancomycin and related antibiotics
0.000 0.997 0.003
U88 Agent resistant to multiple antibiotics
0.000 0.997 0.003
B37.8 Candidiasis of other sites
0.000 0.997 0.003
F42.9 Obsessive-compulsive disorder, unspecified
0.003 0.997 0.000
E24.9 Cushing's syndrome, unspecified
0.001 0.997 0.002
J31.1 Chronic nasopharyngitis
0.000 0.997 0.003
F45.3 Somatoform autonomic dysfunction
0.003 0.997 0.000
S82.50 Fracture of medial malleolus (closed)
0.003 0.997 0.000
U84 Resistance to other antimicrobial drugs
0.000 0.997 0.003
U83 Resistance to other antibiotics
0.000 0.997 0.003
U82 Resistance to betalactam antibiotics
0.000 0.997 0.003
U85 Resistance to antineoplastic drugs
0.000 0.997 0.003
M81.4 Drug-induced osteoporosis
0.000 0.997 0.003
D45 Polycythaemia vera
0.000 0.997 0.003
K86.0 Alcohol-induced chronic pancreatitis
0.000 0.997 0.003
M43.0 Spondylolysis
0.003 0.997 0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot
0.000 0.997 0.003
J41.0 Simple chronic bronchitis
0.000 0.997 0.003
I71 Aortic aneurysm and dissection
0.003 0.997 0.000
S02.00 Fracture of vault of skull (closed)
0.000 0.997 0.003
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture
0.003 0.997 0.000
M43.09 Spondylolysis (Site unspecified)
0.003 0.997 0.000
F43.1 Posttraumatic stress disorder
0.003 0.997 0.000
M81.3 Postsurgical malabsorption osteoporosis
0.000 0.997 0.003
M81.6 Localised osteoporosis [Lequesne]
0.000 0.997 0.003
M81.5 Idiopathic osteoporosis
0.000 0.997 0.003
M81.1 Postoophorectomy osteoporosis
0.000 0.997 0.003
A63 Other predominantly sexually transmitted diseases, not elsewhere classified
0.003 0.997 0.000
M81.2 Osteoporosis of disuse
0.000 0.997 0.003
I71.1 Thoracic aortic aneurysm, ruptured
0.003 0.997 0.000
M81.8 Other osteoporosis
0.000 0.997 0.003
M81.40 Drug-induced osteoporosis (Multiple sites)
0.000 0.997 0.003
U04.9 Severe acute respiratory syndrome [SARS], unspecified
0.000 0.997 0.003
U06.9 Emergency use of U06.9
0.000 0.997 0.003
U06.8 Emergency use of U06.8
0.000 0.997 0.003
U06.7 Emergency use of U06.7
0.000 0.997 0.003
U06.6 Emergency use of U06.6
0.000 0.997 0.003
U06.5 Emergency use of U06.5
0.000 0.997 0.003
U06.4 Emergency use of U06.4
0.000 0.997 0.003
U06.3 Emergency use of U06.3
0.000 0.997 0.003
U06.2 Emergency use of U06.2
0.000 0.997 0.003
U06.1 Emergency use of U06.1
0.000 0.997 0.003
U06.0 Emergency use of U06.0
0.000 0.997 0.003
U07.9 Emergency use of U07.9
0.000 0.997 0.003
U07.8 Emergency use of U07.8
0.000 0.997 0.003
U07.7 Emergency use of U07.7
0.000 0.997 0.003
U07.6 Emergency use of U07.6
0.000 0.997 0.003
U07.5 Emergency use of U07.5
0.000 0.997 0.003
U07.4 Emergency use of U07.4
0.000 0.997 0.003
U07.3 Emergency use of U07.3
0.000 0.997 0.003
U07.2 Emergency use of U07.2
0.000 0.997 0.003
U07.1 Emergency use of U07.1
0.000 0.997 0.003
U07.0 Emergency use of U07.0
0.000 0.997 0.003
U50.9 Inquest Adjourned Death
0.000 0.997 0.003
U50.3 Level of care administered to neonates (Maximal Intensive Care)
0.000 0.997 0.003
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)
0.000 0.997 0.003
U50.1 Level of care administered to neonates (Special Care)
0.000 0.997 0.003
U50.0 Level of care administered to neonates (Normal Care)
0.000 0.997 0.003
E04 Other non-toxic goitre
0.000 0.997 0.003
U51 Admission status on psychiatric patients
0.000 0.997 0.003
I71.9 Aortic aneurysm of unspecified site, without mention of rupture
0.003 0.997 0.000
M81.0 Postmenopausal osteoporosis
0.000 0.997 0.003
J04.0 Acute laryngitis
0.000 0.997 0.003
U81.0 Vancomycin resistant agent
0.000 0.997 0.003
J37 Chronic laryngitis and laryngotracheitis
0.000 0.997 0.003
Z93.1 Gastrostomy status
0.000 0.997 0.003
U81.8 Agent resistant to other vancomycin-related antibiotic
0.000 0.997 0.002
E61.1 Iron deficiency
0.000 0.997 0.002
M43.2 Other fusion of spine
0.003 0.997 0.000
S30.2 Contusion of external genital organs
0.003 0.997 0.000
F42 Obsessive-compulsive disorder
0.003 0.997 0.000
S52.00 Fracture of upper end of ulna (closed)
0.000 0.997 0.003
C81 Hodgkin's disease
0.000 0.997 0.003
A63.8 Other specified predominantly sexually transmitted diseases
0.002 0.997 0.000
J04.1 Acute tracheitis
0.000 0.997 0.003
M81.49 Drug-induced osteoporosis (Site unspecified)
0.000 0.997 0.002
U82.9 Resistance to betalactam antibiotics, unspecified
0.000 0.997 0.002
U82.8 Resistance to other betalactam antibiotics
0.000 0.997 0.002
U82.2 Extended spectrum betalactamase (ESBL) resistance
0.000 0.997 0.002
U82.1 Resistance to methicillin
0.000 0.997 0.002
U82.0 Resistance to penicillin
0.000 0.997 0.002
U83.9 Resistance to unspecified antibiotic
0.000 0.997 0.002
U83.8 Resistance to other single specified antibiotic
0.000 0.997 0.002
U83.7 Resistance to multiple antibiotics
0.000 0.997 0.002
U83.2 Resistance to quinolones
0.000 0.997 0.002
U83.1 Resistance to other vancomycin related antibiotics
0.000 0.997 0.002
U83.0 Resistance to vancomycin
0.000 0.997 0.002
U84.9 Resistance to unspecified antimicrobial drugs
0.000 0.997 0.002
U84.8 Resistance to other specified antimicrobial drug
0.000 0.997 0.002
U84.7 Resistance to multiple antimicrobial drugs
0.000 0.997 0.002
U84.3 Resistance to tuberculostatic drug(s)
0.000 0.997 0.002
U84.2 Resistance to antiviral drug(s)
0.000 0.997 0.002
U84.1 Resistance to antifungal drug(s)
0.000 0.997 0.002
U84.0 Resistance to antiparasitic drug(s)
0.000 0.997 0.002
M81.48 Drug-induced osteoporosis (Other)
0.000 0.997 0.002
M81.47 Drug-induced osteoporosis (Ankle and foot)
0.000 0.997 0.002
M81.46 Drug-induced osteoporosis (Lower leg)
0.000 0.997 0.002
M81.45 Drug-induced osteoporosis (Pelvic region and thigh)
0.000 0.997 0.002
M81.44 Drug-induced osteoporosis (Hand)
0.000 0.997 0.002
M81.43 Drug-induced osteoporosis (Forearm)
0.000 0.997 0.002
M81.42 Drug-induced osteoporosis (Upper arm)
0.000 0.997 0.002
M81.41 Drug-induced osteoporosis (Shoulder region)
0.000 0.997 0.002
L20.9 Atopic dermatitis, unspecified
0.000 0.997 0.003
M43.07 Spondylolysis (Lumbosacral region)
0.002 0.997 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.997 0.003
M43.29 Other fusion of spine (Site unspecified)
0.002 0.997 0.000
C84.4 Peripheral T-cell lymphoma
0.000 0.997 0.002
D59.1 Other autoimmune haemolytic anaemias
0.000 0.997 0.002
T43.5 Other and unspecified antipsychotics and neuroleptics
0.002 0.997 0.000
J45.0 Predominantly allergic asthma
0.000 0.998 0.002
M43.08 Spondylolysis (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M43.05 Spondylolysis (Thoracolumbar region)
0.002 0.998 0.000
M43.04 Spondylolysis (Thoracic region)
0.002 0.998 0.000
M43.03 Spondylolysis (Cervicothoracic region)
0.002 0.998 0.000
M43.01 Spondylolysis (Occipito-atlanto-axial region)
0.002 0.998 0.000
M43.00 Spondylolysis (Multiple sites in spine)
0.002 0.998 0.000
M43.22 Other fusion of spine (Cervical region)
0.002 0.998 0.000
M43 Other deforming dorsopathies
0.002 0.998 0.000
W55.0 Home
0.000 0.998 0.002
F81.9 Developmental disorder of scholastic skills, unspecified
0.002 0.998 0.000
I71.8 Aortic aneurysm of unspecified site, ruptured
0.002 0.998 0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured
0.002 0.998 0.000
M46.06 Spinal enthesopathy (Lumbar region)
0.002 0.998 0.000
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified
0.002 0.998 0.000
F42.1 Predominantly compulsive acts [obsessional rituals]
0.002 0.998 0.000
L40.0 Psoriasis vulgaris
0.000 0.998 0.002
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.998 0.002
M81.30 Postsurgical malabsorption osteoporosis (Multiple sites)
0.000 0.998 0.002
J31.2 Chronic pharyngitis
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.